CIK 0001759425 · Large accelerated filer
Mirum Pharmaceuticals, Inc.
Sign in to watch- Ticker
- MIRM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831281555
- Phone
- 650-667-4085
- Business address
- 989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,138,950
- in 6 filings, $4.8M under 10b5-1 plans
Net −$11,138,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-29 | Ramasastry Saira Director | Option exercise · Restricted Stock Units | −3,977 | 0 | ||
| 2026-05-29 | Fischer Laurent Director | Option exercise | +3,977 | 10,727 | ||
| 2026-05-29 | Fischer Laurent Director | Option exercise · Restricted Stock Units | −3,977 | 0 | ||
| 2026-05-29 | Walbert Timothy P Director | Option exercise | +3,977 | 9,680 | ||
| 2026-05-29 | Walbert Timothy P Director | Option exercise · Restricted Stock Units | −3,977 | 0 | ||
| 2026-05-15 | Ramasastry Saira Director | Option exercise 10b5-1 | +2,000 | $23.51 | $47K | 2,000 |
| 2026-05-15 | Ramasastry Saira Director | Sale 10b5-1 | −2,000 | $109.47 | $219K | 0 |
| 2026-05-15 | Ramasastry Saira Director | Option exercise · Stock Option (right to buy) 10b5-1 | −2,000 | 0 | ||
| 2026-04-15 | Ramasastry Saira Director | Option exercise 10b5-1 | +2,000 | $23.51 | $47K | 2,000 |
| 2026-04-15 | Ramasastry Saira Director | Sale 10b5-1 | −2,000 | $96.90 | $194K | 0 |
| 2026-04-15 | Ramasastry Saira Director | Option exercise · Stock Option (right to buy) 10b5-1 | −2,000 | 2,000 | ||
| 2026-03-16 | Howe Jolanda SVP, GLOBAL CONTROLLER | Sale | −4,732 | $91.98 | $435K | 8,429 |
| 2026-03-16 | Quan Joanne CHIEF MEDICAL OFFICER | Sale | −7,287 | $91.98 | $670K | 18,864 |
| 2026-03-16 | Radovich Peter PRESIDENT AND COO | Sale | −16,515 | $91.98 | $1.5M | 40,272 |
| 2026-03-16 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Sale | −40,985 | $91.98 | $3.8M | 194,309 |
| 2026-03-16 | Ramasastry Saira Director | Option exercise 10b5-1 | +2,000 | $23.51 | $47K | 2,000 |
| 2026-03-16 | Ramasastry Saira Director | Sale 10b5-1 | −2,000 | $90.76 | $182K | 0 |
| 2026-03-16 | Ramasastry Saira Director | Option exercise · Stock Option (right to buy) 10b5-1 | −2,000 | 4,000 | ||
| 2026-03-16 | BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | Sale | −7,287 | $91.98 | $670K | 49,788 |
| 2026-03-15 | Howe Jolanda SVP, GLOBAL CONTROLLER | Option exercise | +2,658 | 7,161 |
Page 5 of 15 · 294 trades